Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hcw Biologics Inc (HCWB)

Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hcw Biologics Inc 2929 N COMMERCE PKWY MIRAMAR FL 33025 USA

www.hcwbiologics.com Employees: 36 P: 954-842-2024

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

HCW Biologics Inc. is a preclinical stage biopharmaceutical company. It focused on discovering and developing novel immunotherapies. HCW Biologics Inc. is based in MIRAMAR, Fla.

Key Statistics

Overview:

Market Capitalization, $K 1,773
Enterprise Value, $K 10,793
Shares Outstanding, K 3,280
Float, K 1,879
% Float 57.30%
Short Interest, K 24
Short Float 0.72%
Days to Cover 1.00
Short Volume Ratio 0.39
% of Insider Shareholders 42.70%
% of Institutional Shareholders 2.96%

Financials:

Annual Sales, $ 2,570 K
Annual Net Income, $ -30,020 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -4,550 K
EBIT, $ -11,880 K
EBITDA, $ -10,700 K

Growth:

1-Year Return -96.38%
3-Year Return -99.21%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.02 on 11/14/25
Next Earnings Date 03/27/26 [--]
Earnings Per Share ttm -12.06
EPS Growth vs. Prev Qtr 70.25%
EPS Growth vs. Prev Year 49.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 04/11/25

HCWB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -43.48%
Profit Margin % -1,168.09%
Debt/Equity -3.23
Price/Sales 1.97
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.98
Interest Coverage -46.65
60-Month Beta 0.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar